Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation

Por Chang, Yan, Fang, Wenfang B., Lin, Shen-Nan, Moody, David E.
Publicado em 2010

The phospholipids of the hepatic endoplasmic reticulum. Structural change in liver injury

Por James, Jacqueline L., Moody, David E., Chan, Christine H., Smuckler, Edward A.
Publicado em 1982

Gender Differences in Pharmacokinetics of Maintenance Dosed Buprenorphine

Por Moody, David E., Fang, Wenfang B., Morrison, Jerdravee, McCance-Katz, Elinore
Publicado em 2011

Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid Chromatography–Electrospray Ionization-Tandem Mass Spectrometry in Human Matrices: In vivo and I...

Por Fang, Wenfang B., Lofwall, Michelle R., Walsh, Sharon L., Moody, David E.
Publicado em 2013

The In Vivo Response of Novel Buprenorphine Metabolites, M1 and M3, to Antiretroviral Inducers and Inhibitors of Buprenorphine Metabolism

Por Moody, David E., Chang, Yan, Huang, Wei, McCance-Katz, Elinore F.
Publicado em 2009

Effects of HCV Seropositive Status on Buprenorphine Pharmacokinetics in Opioid-Dependent Individuals

Por Masson, Carmen L., Rainey, Petrie M., Moody, David E., McCance-Katz, Elinore F.
Publicado em 2013

Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography–Tandem Mass Spectrometry

Por Andrenyak, David M., Moody, David E., Slawson, Matthew H., O'Leary, Daniel S., Haney, Margaret
Publicado no J Anal Toxicol (2017)

Repeated Dosing with Oral Cocaine in Humans: Assessment of Direct Effects, Withdrawal and Pharmacokinetics

Por Walsh, Sharon L., Stoops, William W., Moody, David E., Lin, Shen-Nan, Bigelow, George E.
Publicado em 2009

Rifampin, but not Rifabutin, May Produce Opiate Withdrawal in Buprenorphine-Maintained Patients*

Por McCance-Katz, Elinore F., Moody, David E., Prathikanti, Sudha, Friedland, Gerald, Rainey, Petrie M.
Publicado em 2011

A Review of Pharmacological Interactions Between HIV or HCV Medications and Opioid Agonist Therapy: Implications and Management for Clinical Practice

Por Bruce, R. Douglas, Moody, David E., Altice, Frederick L., Gourevitch, Marc N., Friedland, Gerald H.
Publicado em 2013

Cocaine Cardiovascular Effects and Pharmacokinetics after Treatment with the Acetylcholinesterase Inhibitor Donepezil

Por Grasing, Kenneth, Mathur, Deepan, DeSouza, Cherilyn, Newton, Thomas F., Moody, David E., Sturgill, Marc
Publicado no Am J Addict (2016)

Lack of Clinically Significant Drug Interactions between Nevirapine and Buprenorphine

Por McCance-Katz, Elinore F., Moody, David E., Morse, Gene D., Ma, Qing, Rainey, Petrie M.
Publicado em 2010

Pharmacokinetics of 2 Formulations of Buprenorphine in Macaques (Macaca mulatta and Macaca fascicularis)

Por Nunamaker, Elizabeth A, Halliday, Lisa C, Moody, David E, Fang, Wenfang B, Lindeblad, Matthew, Fortman, Jeffrey D
Publicado em 2013

Effect of Rifampin and Nelfinavir on the Metabolism of Methadone and Buprenorphine in Primary Cultures of Human Hepatocytes

Por Moody, David E., Fang, Wenfang B., Lin, Shen-Nan, Weyant, Denise M., Strom, Stephen C., Omiecinski, Curtis J.
Publicado em 2009

Formulation of Buprenorphine for Sublingual Use in Neonates

Por Anagnostis, Ellena A., Sadaka, Rania E., Sailor, Linda A., Moody, David E., Dysart, Kevin C., Kraft, Walter K.
Publicado em 2011

Interactions between Buprenorphine and Antiretrovirals: Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir

Por Baker, Jennifer, Rainey, Petrie M., Moody, David E., Morse, Gene D., Ma, Qing, McCance-Katz, Elinore F.
Publicado em 2010

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Por Ng, Chee M., Dombrowsky, Erin, Lin, Hopi, Erlich, Michelle E., Moody, David E., Barrett, Jeffrey S., Kraft, Walter K.
Publicado no Pharmacotherapy (2015)

The Cardiovascular and Subjective Effects of Methamphetamine Combined with γ-vinyl-γ-aminobutyric acid (GVG) in Non-Treatment Seeking Methamphetamine-dependent Volunteers

Por De La Garza, Richard, Zorick, Todd, Heinzerling, Keith G., Nusinowitz, Steve, London, Edythe D., Shoptaw, Steven, Moody, David E., Newton, Thomas F.
Publicado em 2009

Sublingual Buprenorphine for Treatment of the Neonatal Abstinence Syndrome: A Randomized Trial

Por Kraft, Walter K., Gibson, Eric, Dysart, Kevin, Damle, Vidula S., LaRusso, Jennifer L., Greenspan, Jay S., Moody, David E., Kaltenbach, Karol, Ehrlich, Michelle E.
Publicado em 2008

Interaction Between Buprenorphine and Atazanavir or Atazanavir/Ritonavir

Por McCance-Katz, Elinore F., Moody, David E., Morse, Gene D., Ma, Qing, DiFrancesco, Robin, Friedland, Gerald, Pade, Patricia, Rainey, Petrie M.
Publicado em 2007